Design of lifestyle intervention trials to prevent excessive gestational weight gain in women with overweight or obesity

Abstract
Objective The Lifestyle Interventions for Expectant Moms (LIFE‐Moms) Consortium is designed to determine, in pregnant women with overweight or obesity, whether various behavioral and lifestyle interventions reduce excessive gestational weight gain (GWG) and subsequent adverse maternal and neonatal outcomes and obesity in offspring. The design and planning process of the LIFE‐Moms Consortium is described. Methods The LIFE‐Moms Consortium is a collaboration among seven clinical centers, a Research Coordinating Unit, and the NIH designed to support each clinical center's conduct of a separate trial of a unique intervention. Specific common measures, procedures, and eligibility criteria are consistent across the seven trials allowing data to be combined in exploratory analyses and/or compared readily. Results Numerous committees and working groups were created to define common measures and outcomes during pregnancy and through 1 year postpartum, develop Consortium policies, and oversee progress of the trials. The primary outcome for the Consortium is excessive GWG. Secondary outcomes include maternal, neonatal, and infant anthropometric measures, physical activity, sleep, and complications of pregnancy and delivery. Conclusions A multi‐center consortium of independent, lifestyle interventions with common measures and outcomes may enhance the ability to identify promising interventions for improving outcomes in pregnant women and their offspring.
Funding Information
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, U01 DK094418, U01 DK094463, U01 DK094416, 5U01 DK094466 [RCU])
  • National Institutes of Health (NIH) through The, The National Heart, Lung, and Blood Institute (NHLBI, U01 HL114344, U01 HL114377)
  • the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, U01 HD072834)
  • NIDDK Obesity Nutrition Research Centers (P30 DK026687, P30 DK072476, P30 DK56341, P30 DK026687, P30 DK072476, P30 DK56341)
  • National Center for Advancing Translational Sciences Clinical and Translational Science Awards (U54 GM104940, U54 MD007587, UL1 RR024992)
  • National Institute on Minority Health and Health Disparities (S21MD001830)